Kava in Arnhem Land: A review of consumption and its social correlates

Drug and Alcohol Review

Volumn 19, Issue 3, 2000, Pages 319-328

  Clough, Alan R ^a,b   Burns, Christopher B ^a   Mununggurr, Ngarrawu ^a  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b NONE   (Australia)

Author keywords

Arnhem Land; Dosage; Kava; Pacific island societies; Social context of consumption

Indexed keywords

EID: 0034417597     PISSN: 09595236     EISSN: None     Source Type: Journal    
DOI: 10.1080/713659370     Document Type: Article

References (51)

1. Duffield A, Jamieson D. Chemistry and pharmacology of kava, Kava: use and abuse in Australia and the South Pacific, University of New South Wales, 1988. Vol. Monograph No. 5. National Drug and Alcohol Research Centre.
2. Shulgin A. The narcotic pepper - the chemistry and pharmacology of Piper methysticum and related species. Bulletin on Narcotics 1973;25:59-74.
3. Prescott J. Kava use in Australia. Drug Alcohol Rev 1990;9:325-28.
4. Mathews J, Riley M, Fejo L, Munoz E, Milns N, Gardner I, et al. Effects of the heavy usage of kava on physical health: summary of a pilot survey in an Aboriginal community. Med J Aust 1988;148:548-55.
5. Alexander K. Kava in the North: a study of kava in Arnhem Land Aboriginal Communities. Darwin: Australian National University North Australia Research Unit, 1985.
6. Alexander K, Watson C, Fleming J. Kava in the north: a study of kava in Arnhem Land Aboriginal communities. Aboriginal Health Information Bulletin 1988;10:32-7.
7. D'Abbs E A review of kava control measures in the Northern Territory. Darwin: Menzies School of Health Research, 1993.
8. D'Abbs P, Burns C. Report on Inquiry into the Issue of Kava Regulation. Darwin: Legislative Assembly of the Northern Territory, Menzies School of Health Research, 1997.
9. Schulz D. Dying for a drink. The Bulletin, 1997:18-19.
10. Prescott J, McCall G. Introduction, Kava: use and abuse in Australia and the South Pacific, University of New South Wales, 1988. Vol. Monograph No. 5. National Drug and Alcohol Research Centre.
11. Burke (The Hon.) D. Media release. Parliament House, Darwin, 1998:2.
12. Northern Territory of Australia. Kava Management Act. Darwin: Territory Health Services, 1998.
13. Northern Territory of Australia. Kava Management Regulations. Darwin: Territory Health Services, 1998.
14. Miwatj Health Aboriginal Corporation. Summary of a Review of kava control measures in the Northern Territory: Unpublished manuscript, 1993.
15. Burke (The Hon.) D. Ministerial Statement, Kava Management. In: Seventh Assembly First Session NTP, ed: Legislative Assembly of the Northern Territory, 1996.
16. Alcohol and Other Drugs Program. Kava control in the Northern Territory Discussion Paper. Darwin: Territory Health Services, 1993.
17. Mackay I. Kava: an information paper: Unpublished Paper, National Food Authority, Canberra, 1995.
18. Cheng D, Lidgard RO, Duffield PH, Duffield A. Identification by methane chemical ionization gas chromatography/mass spectrometry of the products obtained by steam distillation and aqueous acid extraction of commercial Piper methysticum. Biomed Environ Mass Spectrom 1988;17:371-76.
19. Jamieson D, Duffield P. Positive interaction of ethanol and kava resin in mice. Clin Exp Pharmacol Physiol 1990;17:509-14.
20. Duffield P, Jamieson D. Development of tolerance to kava in mice. Clinical and Exp Pharmacol Physiol 1991;18:571-8.
21. Cawte J. Parameters of kava used as a challenge to alcohol. Aus Z J Psychiatry 1986;20:70-6.
22. Gerrard G. Use of kava in two Aboriginal settlements, Kava: use and abuse in Australia and the South Pacific, University of New South Wales, 1988. Vol. Monograph No. 5. National Drug and Alcohol Research Centre.
23. Reid J. Sorcerers and Healing Spirits. Canberra: Australian National University, 1983.
24. Williams N. The Yolngu and their land: a system of land tenure and the fight for its recognition. Canberra: Australian Institute of Aboriginal Studies, 1986.
25. Riley M, Mathews J. Heavy kava use by Aboriginal Australians, Kava: use and abuse in Australia and the South Pacific, University of New South Wales, 1988. Vol. Monograph No. 5. National Drug and Alcohol Research Centre.
26. Lebot V, Merlin M, Lindstrom L. Kava, the Pacific Elixir: The definitive guide to its ethnobotany, history and chemistry. Rochester, Vermont: Healing Arts Press, 1997:255.
27. Ring I. A 'whole of government' approach needed on indigenous health. A N Z J Public Health 1998;22: 639-40.
28. Grady D. Kava may soothe jagged nerves, but is it safe? New York Times. New York, 1998:F7.
29. Duve RN, Prasad J. Efficacy of extraction of constituents in the preparation of yaqona beverage. Pat 2: major active constituents. Fiji Agric J 1984;46: 11-16.
30. Brunton R. A harmless substance? Anthropological aspects of kava in the South Pacific, Kava: use and abuse in Australia and the South Pacific, University of New South Wales, 1988. Vol. Monograph No. 5. National Drug and Alcohol Research Centre.
31. Koch M, Plat M, Mehri H, Saillant J-P, Kornowski H. Dosage des kawalactones totales et des dihydro-5,6 kawalactones dans les preparations de kawa. Annales Pharmaceutiques Francaises 1973;31:133-138.
32. Furgiuele A, Kinnard W, AcetoM, Buckley J. Central activity of aqueous extracts of Piper methysticum (kava). Journal of Pharmaceutical Sciences 1965;54: 247-52.
33. Duve RN, Prasad J. Efficacy of extraction of constituents in the preparation of yaqona beverage. Pat 1: general constituents. Fiji Agric J 1984;46:5-9.
34. Duve RN, Prasad J. Quality evaluation of yaqona (Piper methysticum) in Fiji. Fiji Agric J 1981;43:l-8.
35. Duve RN, Prasad J. Changes in the chemical composition of "yaqona" (Piper methysticum) with time. Fiji Agric J 1983;45:45-50.
36. Dunlop I. We believe in it: we know it's true. Lindfield, NSW: Film Australia, 1996.
37. Lebot V, Merlin M, Lindstrom L. Kava: The Pacific drug. New Haven: Yale University Press, 1992.
38. Ruze P. Kava-induced dermopathy: a niacin deficiency? Lancet 1990;335:1442-5.
39. Frater A. Medical aspects of yaqona. Transactions and Proceedings of the Fijian Society 1952;5:31-39.
40. Munte T, Heinze H, Matzke M, Steitz W. Effects of oxazepam and an extract of kava roots (Piper methysticum) on event-related potentials in a word recognition task. Neuropsychobiol 1993;27:46-53.
41. Schelosky L, Raffauf C, Jendroska K, Poewe W. Kava and dopamine antagonism. J Neurol Neurosurg Psychiatry 1995;58:639-640.
42. Russell P, Bakker D, Singh N. The effects of kava on alerting and speed of access of information from longterm memory. Bull Psychonomic Society 1987;25: 236-7.
43. Prescott J, Jamieson D, Emdur N, Duffield P Acute effects of kava on measures of cognitive performance, physiological function and mood. Drug Alcohol Rev 1993;12:49-58.
44. Foo H, Lemon J. Acute effects of kava, alone or in combination with alcohol, on subjective measures of impairment and intoxication and on cognitive performance. Drug Alcohol Rev 1997;16: 147-55.
45. Ratiopharm GmbH & Co. Kava-ratiopharm, nd.
46. Editorial. Kava comes to Australia. Aboriginal Health Worker 1984;8:9-10.
47. Cawte J. Healers of Arnhem Land. Sydney: University of New South Wales, 1996.
48. Cawte J. Psychoactive substances of the South Seas: betel, kava and pituri. Aust N Z J Psychiatry 1985;19.
49. Pollock N. Introduction: the power of kava. Canberra Anthropology 1995;18:1-19.
50. Cawte J. Macabre effects of a 'cult' for kava. Med J Aust 1988;148:545-6.
51. Gregory R, Cawte J. The principle of alien poisons: contrasting psychopharmacology of kava in Oceania and Australia, Kava: Use and abuse in Australia and the South Pacific, University of New South Wales, 1988. Vol. Monograph No. 5. National Drug and Alcohol Research Centre.